-
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Study
EGAS00001006200
-
WXS and RNA-seq for 22 patients treated with radiation + immunotherapy
Study
EGAS00001006212
-
Targeted_NanoSeq_Sperm
Study
EGAS00001005920
-
The Proteogenomic Subtypes of Acute Myeloid Leukemia
Study
EGAS00001005950
-
RNA-seq on patient-derived, stage II, CRC cell lines
Study
EGAS00001005948
-
RNA-sequencing data from metastatic Castration-Resistant Prostate Cancer (mCRPC)
Study
EGAS00001005954
-
An Isogenic Cell Line Panel for Sequence-based Screening of Targeted Anti-cancer Drugs
Study
EGAS00001005974
-
Intratumoural heterogeneity and immune modulation in lung adenocarcinoma of female smokers and never smokers
Study
EGAS00001006331
-
Specific BRCA and immune configurations determine optimal response to platinum-based chemotherapy in triple negative breast and ovarian carcinomas (COH_TNBC_RNAseq)
Study
EGAS00001006002
-
Single cell genomic variation induced by mutational processes in cancer
Study
EGAS00001006343
-
Single cell RNA sequencing of colorectal cancer patients (CRC-SG1)
Study
EGAS00001006013
-
Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence (ChIP-seq)
Study
EGAS00001006017
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-2)
Study
EGAS00001006039
-
Comparison of sequencing assays for sensitive detection of circulating tumour DNA in stage IA-IV breast cancer
Study
EGAS00001006040
-
Single cell RNA sequencing of colorectal cancer patients (KUL3/KUL5)
Study
EGAS00001006049
-
CD8+ Tumor-Infiltrating Lymphocyte Abundance is a Positive Prognostic Indicator in Nasopharyngeal Cancer
Study
EGAS00001006396
-
Application of high-throughput, high-depth, targeted single-nucleus DNA sequencing in pancreatic cancer
Study
EGAS00001006024
-
Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies unique proteotypes associated with patient outcomes
Study
EGAS00001006068
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-4)
Study
EGAS00001006101
-
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer
Study
EGAS00001006118
-
Genetic immune escape landscape in primary and metastatic cancer
Study
EGAS00001006123
-
Loss of Epigenetic Barrier is Required for Enhancer Hijacking-Mediated Oncogenic Transcription
Study
EGAS00001006140
-
Phase 1 CX-5461 Trial (Canadian Cancer Trials Group Trial IND.231)
Study
EGAS00001006173
-
DNA methylation-based prognostic subtypes of chordoma tumors in tissue
Study
EGAS00001006406
-
Prostate cancer ancestral genomic disparity
Study
EGAS00001006425
-
Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions
Study
EGAS00001006293
-
Molecular Classification of Hormone Sensitive and Castration Resistant prostate cancer, using non-negative matrix factorization molecular subtyping
Study
EGAS00001006204
-
Germline sequencing
Study
EGAS00001006254
-
Germline variant analysis in childhood AML
Study
EGAS00001006276
-
Colorectal cancer genomics with primary and metastatic samples
Study
EGAS00001006465
-
Deep whole genome sequencing identifies recurrent genomic alterations in breast cancer cell lines and patient derived xenograft models
Study
EGAS00001006285
-
RP-1843 Arcagen - Gastrointestinal rare cancers (GI)
Study
EGAS00001006299
-
Clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancers defined by genomic analysis
Study
EGAS00001006306
-
Organoid_Derivation_Project___GRCh38___TGS
Study
EGAS00001007349
-
Childhood Cancer Model Atlas
Study
EGAS00001006320
-
Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer
Study
EGAS00001006334
-
Genetic and epigenetic variation at regulatory regions contribute to cancer evolution under endocrine treatment
Study
EGAS00001006340
-
Clonal dominance defines metastatic dissemination in pancreatic cancer
Study
EGAS00001006358
-
Widespread hypertranscription in aggressive human cancers
Study
EGAS00001006365
-
Tumor microenvironment study of ovarian granulosa cell tumors
Study
EGAS00001006478
-
RNA-seq analysis of metastatic prostate cancer solid tumor biopsies
Study
EGAS00001006369
-
Finding structural variation from the human skin fibroblast at the single-cell level
Study
EGAS00001006498
-
Plasma whole genome sequencing from patients with stage IV colorectal cancer and microsatellite instability
Study
EGAS00001006377
-
Somatic Inactivation of Breast Cancer Predisposition Genes in Tumours Associated with Pathogenic Germline Variants
Study
EGAS00001006532
-
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers
Study
EGAS00001006393
-
Resolving the immune landscape of human prostate at a single cell level in health and cancer
Study
EGAS00001005787
-
Colorectal cancer transcriptomics with primary and metastatic samples
Study
EGAS00001006464
-
Detection of Gene Fusions using Targeted Next-Generation Sequencing – a Comparative Evaluation
Study
EGAS00001004934
-
Bulk RNA-seq of stromal cells from multiple cancer types
Study
EGAS00001006497
-
Single-cell multi-omics of relapse/refractory multiple myeloma patients (Hipo K08K/H067/K43R)
Study
EGAS00001006538
-
Genomic analysis and evolutionary modeling of breast and larynx cancer, based on specimens from Polish population
Study
EGAS00001006456
-
Single Cell Dissection of the Tumour Microenvironment Reveals Dynamic Interplay Shaping the Tumour Immunity Continuum in Ovarian Cancer
Study
EGAS00001004935
-
Multi-focal genomic dissection of synchronous primary and metastatic tissue from de novo metastatic prostate cancer
Study
EGAS00001006466
-
Real-time analysis of the cancer genome and fragmentome from plasma and urine short and long cell-free DNA using Nanopore sequencing
Study
EGAS00001006591
-
Germline sequencing
Study
EGAS00001006705
-
Multi-institutional collaboration to characterize 5hmC in prostate cancer, both tumor biopsies and cfDNA.
Study
EGAS00001004942
-
Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA.
Study
EGAS00001006553
-
Genetic insights into the biological mechanisms governing human ovarian ageing
Study
EGAS00001004947
-
Colorectal cancer study
Study
EGAS00001006489
-
Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients
Study
EGAS00001006490
-
germline variants in children with hematological cancer
Study
EGAS00001006907
-
Multi-region RNA sequencing of tumour regions and tumour-adjacent normal lung tissue
Study
EGAS00001006517
-
Gene signature for predicting homologous recombination deficiency in triple-negative breast cancer
Study
EGAS00001006518
-
DERMATLAS__Tubular_adenoma
Study
EGAS00001006686
-
Characterization of MCSP+ melanoma DCC and MelDCC lines
Study
EGAS00001006702
-
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers
Study
EGAS00001004953
-
cfDNA in Hereditary And High-Risk Malignancies (CHARM)
Study
EGAS00001006539
-
The University of Hong Kong Colon Cancer GCV Study
Study
EGAS00001006707
-
Exome sequencing from cfDNA blood samples. 159 samples at 2x101bp Illumina reads in Fastq format.
Study
EGAS00001006656
-
Evaluation of capture and amplicon-based targeted sequencing methods on formalin-fixed tumours
Study
EGAS00001004965
-
Deciphering somatic mosaic structural variation in human blood lineages using single-cell multiomics
Study
EGAS00001006567
-
Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models: validation cohort
Study
EGAS00001006582
-
PDAC organoid genomic heterogeneity
Study
EGAS00001006782
-
Treatment-mediated selection of lethal prostate cancer clones defined by copy number architectures
Study
EGAS00001006598
-
Hi-C analysis of metastatic prostate tumors
Study
EGAS00001006604
-
Integrative analysis of exome-seq, RNA-seq, ATAC-seq (bulk and single-cell), and Hi-C data generated from 3-D spatially mapped samples acquired during surgical resection from 10 patients diagnosed with IDH-WT glioblastoma
Study
EGAS00001006785
-
The clinical utility of genomics in childhood cancer extends beyond targetable mutations - WGS data
Study
EGAS00001006610
-
Hi-C analysis of metastatic prostate tumors - Part 2
Study
EGAS00001006612
-
Long-read sequencing of diagnosis and post-therapy medulloblastoma reveals complex rearrangement patterns and epigenetic signatures (Hipo_021)
Study
EGAS00001006629
-
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways
Study
EGAS00001006631
-
Identification of neoantigen from MSI-CRC patient derived organoids and its application for targeting by autologous T cells
Study
EGAS00001006633
-
The clinical utility of genomics in childhood cancer extends beyond targetable mutations - Cancer Panel data
Study
EGAS00001006642
-
Whole genome analysis of pediatric patients with medulloblastoma
Study
EGAS00001006653
-
DNA methylation landscape of prostate cancer
Study
EGAS00001006670
-
Recurrent DNMT3B gene rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL
Study
EGAS00001007383
-
Genomic Study of Gastric Cancer
Study
EGAS00001005032
-
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation
Study
EGAS00001006678
-
Identification of genomic aberrations in low-grade serous ovarian cancer
Study
EGAS00001006679
-
DERMATLAS__Tubular_adenoma_RNAseq
Study
EGAS00001006685
-
The molecular landscape of homologous recombination deficient, end-stage, high grade serous ovarian cancer
Study
EGAS00001006789
-
Single-cell roadmap of immune cell responses in chronic myeloid leukemia
Study
EGAS00001005044
-
Pre-neoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma
Study
EGAS00001006692
-
Tissue DNA, WBC DNA and cfDNA (deep-)sequencing of mCRC patients treated with doublet chemotherapy and anti-EGFR in the CAIRO5 study
Study
EGAS00001006695
-
Characterization of chromatin accessibility in metastatic prostate cancer
Study
EGAS00001006698
-
Discovery of cancer prognostic markers based on comparison of gene expression in colorectal cancer samples.
Study
EGAS00001005068
-
Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer
Study
EGAS00001005071
-
single-stranded DNA study
Study
EGAS00001005093
-
Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling (hipo_021)
Study
EGAS00001006747
-
Structural Expression of BMMF in tissues of colorectal, lung and pancreatic cancer patients
Study
EGAS00001006744
-
Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in ICI-related pneumonitis
Study
EGAS00001006762